Pharmabiz23m
ASIA LABEX to take place from March 20 -22 at Chandigarh
ASIA LABEX, premier platform for the laboratory industry in Asia, and LABOTICA summit that showcases the latest technologies, innovations, and products in the laboratory industry will be taking place ...
Pharmabiz1h
TN DCA to organise training programme for regulatory officers on medical devices on March 20 in Chennai
TN DCA to organise training programme for regulatory officers on medical devices on March 20 in Chennai: Peethaambaran Kunnathoor, Chennai Monday, March 10, 2025, 08:00 Hrs [IST] ...
Pharmabiz1h
India initiates sunset review of anti-dumping duty on TDI imports from EU and Saudi Arabia
Shardul Nautiyal, Mumbai Monday, March 10, 2025, 08:00 Hrs [IST] ...
Pharmabiz1h
IPC 2025 from Dec 19-21 to underscore strengthening young faculty training for postgraduates
IPC 2025 from Dec 19-21 to underscore strengthening young faculty training for postgraduates: Nandita Vijayasimha, Bengaluru Monday, March 10, 2025, 08:00 Hrs [IST] The Indian Pha ...
Pharmabiz1h
FDI equity inflow into pharma sector declines 12% in first nine months of FY25
FDI equity inflow into pharma sector declines 12% in first nine months of FY25: Gireesh Babu, New Delhi Monday, March 10, 2025, 08:00 Hrs [IST] The Foreign Direct Investment (FDI) ...
Pharmabiz1h
NPPA to consider other sources also to fix ceiling prices of some formulations
NPPA to consider other sources also to fix ceiling prices of some formulations: Gireesh Babu, New Delhi Monday, March 10, 2025, 08:00 Hrs [IST] The National Pharmaceutical Pricing ...
Pharmabiz1d
GSK to showcase latest research at the International RSV Symposium to advance RSV prevention in adults
GSK to showcase latest research at the International RSV Symposium to advance RSV prevention in adults: London, UK Saturday, March 8, 2025, 14:00 Hrs [IST] GSK plc will share its ...
Pharmabiz1d
ImmunoGenesis doses 1st patient in phase 1/2 trial of IMGS-101 in combo with balstilimab & zalifrelimab to treat immune-excluded tumours
ImmunoGenesis doses 1st patient in phase 1/2 trial of IMGS-101 in combo with balstilimab & zalifrelimab to treat immune-excluded tumours: Houston Saturday, March 8, 2025, 18:00 Hr ...
Pharmabiz1d
Hutchmed completes enrollment in phase II registration study of fanregratinib for intrahepatic cholangiocarcinoma in China
Hutchmed completes enrollment in phase II registration study of fanregratinib for intrahepatic cholangiocarcinoma in China: Hong Kong, Shanghai Saturday, March 8, 2025, 15:00 Hrs ...
Pharmabiz1d
Beneq & Exosens collaborate on lead-free MCPs with ALD, enhancing precision, performance, and manufacturing efficiency
Beneq & Exosens collaborate on lead-free MCPs with ALD, enhancing precision, performance, and manufacturing efficiency: Espoo, Finland Saturday, March 8, 2025, 17:00 Hrs [IST] Ben ...
Pharmabiz2d
Science symposium on “Dissolution Science and Drug Development” organized by AIPAC
Science symposium on “Dissolution Science and Drug Development” organized by AIPAC: Our Bureau, Mumbai Friday, March 7, 2025, ...
Pharmabiz2d
IISc to host Longevity India Conference – Rise for Healthy Aging from March 10 to 12, 2025 in Bengaluru
IISc to host Longevity India Conference – Rise for Healthy Aging from March 10 to 12, 2025 in Bengaluru: Our Bureau, Bengaluru Saturday, March 8, 2025, 09:00 Hrs [IST] Indian In ...